LVM Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$762K Sell
9,745
-1,465
-13% -$118K 0.06% 90
2026
Q1
$971K Sell
11,210
-986
-8% -$94.5K 0.09% 77
2025
Q4
$1.17M Sell
12,196
-1,505
-11% -$146K 0.11% 71
2025
Q3
$1.3M Sell
13,701
-1,200
-8% -$110K 0.13% 67
2025
Q2
$1.3M Sell
14,901
-400
-3% -$33.9K 0.13% 67
2025
Q1
$1.38M Sell
15,301
-2,802
-15% -$251K 0.15% 65
2024
Q4
$1.45M Sell
18,103
-13,838
-43% -$1.2M 0.16% 63
2024
Q3
$2.51M Hold
31,941
0.29% 51
2024
Q2
$2.51M Sell
31,941
-3,518
-10% -$288K 0.29% 51
2024
Q1
$3.09M Sell
35,459
-5,420
-13% -$463K 0.37% 48
2023
Q4
$3.37M Sell
40,879
-7,335
-15% -$559K 0.43% 46
2023
Q3
$3.78M Sell
48,214
-24,260
-33% -$2.03M 0.53% 43
2023
Q2
$6.38M Sell
72,474
-160
-0.2% -$13.8K 0.85% 35
2023
Q1
$5.86M Sell
72,634
-1,201
-2% -$97.9K 0.81% 37
2022
Q4
$5.74M Sell
73,835
-30,061
-29% -$2.44M 0.83% 38
2022
Q3
$8.39M Sell
103,896
-3,505
-3% -$315K 1.28% 32
2022
Q2
$9.64M Buy
107,401
+6,100
+6% +$618K 1.4% 28
2022
Q1
$11.2M Buy
101,301
+5,190
+5% +$548K 1.48% 27
2021
Q4
$9.94M Buy
96,111
+94,059
+4,584% +$10.9M 1.33% 28
2021
Q3
$257K Buy
2,052
+40
+2% +$5.18K 0.04% 110
2021
Q2
$250K Hold
2,012
0.04% 113
2021
Q1
$238K Buy
2,012
+100
+5% +$11.7K 0.04% 113
2020
Q4
$224K Buy
+1,912
New +$210K 0.04% 111
2020
Q1
Sell
-1,827
Closed -$207K 111
2019
Q4
$207K Buy
+1,827
New +$200K 0.04% 110
2018
Q4
Sell
-2,087
Closed -$205K 109
2018
Q3
$205K Buy
+2,087
New +$193K 0.05% 110
2016
Q3
Sell
-2,497
Closed -$217K 124
2016
Q2
$217K Buy
+2,497
New +$202K 0.06% 105
2015
Q3
Sell
-4,081
Closed -$302K 111
2015
Q2
$302K Hold
4,081
0.1% 88
2015
Q1
$318K Buy
+4,081
New +$309K 0.11% 82

Other funds holding MDT

LVM Capital Management's MDT Position: Q2 2026 in Review

LVM Capital Management reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $118K and leaving 9,745 shares worth $762K. The position accounts for 0.06% of the portfolio, ranked #90.

LVM Capital Management first reported a position in MDT in Q1 2015 and has held it in 28 quarters since. The position peaked at $11.2M in Q1 2022. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • LVM Capital Management held 9,745 shares of Medtronic worth $762K as of Q2 2026.
  • LVM Capital Management sold 1,465 Medtronic shares in Q2 2026, an estimated $118K.
  • Medtronic made up 0.06% of LVM Capital Management's portfolio in Q2 2026, its #90 holding.
  • LVM Capital Management first reported a position in Medtronic in Q1 2015 and has held it in 28 quarters since.
  • LVM Capital Management's Medtronic position peaked at $11.2M in Q1 2022.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on LVM Capital Management's 13F filing for Q2 2026, filed 9 Jul 2026.